Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___	O
Chief	O
Complaint:	O
Chest	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Coronary	O
angiography	O
with	O
drug-eluting	O
stent	O
deployment	O
in	O
the	O
LAD	O
___	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
M	O
with	O
H/O	O
prostate	O
cancer	O
and	O
hyperlipidemia	O
referred	O
from	O
PCP	O
and	O
___	O
office	O
for	O
___	O
week	O
h/o	O
intermittent	O
exertional	O
chest	O
pain	O
and	O
newly	O
discovered	O
T	O
wave	O
inversions	O
on	O
EKG.	O
He	O
reports	O
dull,	O
nonradiating	O
substernal	O
chest	O
pain	O
associated	O
with	O
exertional	O
shortness	O
of	O
breath	O
since	O
___.	O
Episodes	O
last	O
___	O
minutes	O
at	O
a	O
time	O
and	O
resolve	O
with	O
rest.	O
He	O
has	O
had	O
no	O
nausea	O
or	O
vomiting,	O
no	O
diaphoresis.	O
He	O
previously	O
walked	O
on	O
the	O
treadmill	O
regularly	O
for	O
20	O
minutes	O
at	O
a	O
time,	O
but	O
in	O
recent	O
weeks,	O
he	O
has	O
developed	O
this	O
chest	O
pain	O
after	O
only	O
12	O
minutes.	O
Symptoms	O
have	O
been	O
stable,	O
but	O
his	O
PCP	O
was	O
concerned	O
about	O
these	O
symptoms	O
during	O
his	O
routinely	O
scheduled	O
visit	O
this	O
morning.	O
EKG	O
performed	O
in	O
the	O
office	O
showed	O
new	O
TWI	O
in	O
the	O
precordial	O
leads	O
concerning	O
for	O
unstable	O
angina	O
vs.	O
NSTEMI,	O
and	O
the	O
patient	O
was	O
referred	O
to	O
the	O
ED.	O
In	O
the	O
ED,	O
initial	O
vital	O
signs	O
were	O
T	O
97.1	O
HR	O
79	O
BP	O
152/76	O
RR	O
18	O
SaO2	O
100%,	O
and	O
he	O
had	O
no	O
chest	O
pain.	O
Labs	O
were	O
notable	O
for	O
Cr	O
1,	O
troponin-T	O
0.03.	O
EKG	O
showed	O
new	O
TWI	O
anteriorly.	O
He	O
was	O
given	O
ASA	O
325	O
mg	O
and	O
admitted	O
to	O
___	O
for	O
further	O
management.	O
On	O
arrival	O
to	O
the	O
floor,	O
the	O
patient	O
was	O
chest	O
pain	O
free.	O
On	O
review	O
of	O
systems,	O
he	O
denies	O
any	O
prior	O
history	O
of	O
venous	O
thrombosis,	O
pulmonary	O
embolism,	O
bleeding	O
disorders,	O
black	B-Upper_gastrointestinal_haemorrhage
stools	B-Upper_gastrointestinal_haemorrhage
or	O
red	B-Lower_gastrointestinal_haemorrhage
stools.	B-Lower_gastrointestinal_haemorrhage
He	O
denies	O
recent	O
fevers,	O
chills	O
or	O
rigors.	O
Cardiac	O
review	O
of	O
systems	O
is	O
notable	O
for	O
absence	O
of	O
paroxysmal	O
nocturnal	O
dyspnea,	O
orthopnea,	O
ankle	O
edema,	O
palpitations,	O
syncope	O
or	O
presyncope.	O
Past	O
Medical	O
History:	O
1.	O
CAD	O
RISK	O
FACTORS:	O
Dyslipidemia	O
___	O
TC	O
184	O
HDL	O
88	O
LDL	O
78)	O
2.	O
CARDIAC	O
HISTORY:	O
None	O
3.	O
Other	O
PMH:	O
-Prostate	O
cancer	O
s/p	O
brachytherapy	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
died	O
of	O
CHF	O
age	O
___.	O
?	O
MI	O
in	O
maternal	O
GF.	O
No	O
h/o	O
arrhythmia	O
or	O
sudden	O
death.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
GENERAL:	O
___	O
elderly	O
Caucasian	O
man	O
in	O
NAD.	O
Oriented	B-Delirium
x3.	B-Delirium
Mood,	O
affect	O
appropriate.	O
VS:	O
T	O
98.1	O
BP	O
158/69	O
HR	O
58	O
RR	O
18	O
SaO2	O
99%	O
on	O
RA.	O
Wt	O
82.6	O
kg	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
PERRL,	O
EOMI.	O
Conjunctiva	O
were	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
No	O
xanthelasma.	O
NECK:	O
Supple,	O
JVP	O
not	O
visualized	O
at	O
90	O
degrees	O
CARDIAC:	O
PMI	O
located	O
in	O
___	O
intercostal	O
space,	O
midclavicular	O
line.	O
RR,	O
normal	O
S1,	O
S2.	O
No	O
murmurs,	O
rubs	O
or	O
gallops.	O
No	O
thrills,	O
lifts.	O
LUNGS:	O
No	O
chest	O
wall	O
deformities,	O
scoliosis	O
or	O
kyphosis.	O
Resp	O
were	O
unlabored,	O
no	O
accessory	O
muscle	O
use.	O
CTAB--no	O
crackles,	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
non-tender,	O
not	O
distended.	O
No	O
HSM	O
or	O
tenderness.	O
EXTREMITIES:	O
No	O
clubbing,	O
cyanosis	O
or	O
edema.	O
No	O
femoral	O
bruits.	O
SKIN:	O
No	O
stasis	O
dermatitis,	O
ulcers,	B-Pressure_injury
scars,	O
or	O
xanthomas.	O
PULSES:	O
Right:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
DP	O
2+	O
___	O
2+	O
Left:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
DP	O
2+	O
___	O
2+	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
GENERAL:	O
___	O
elderly	O
man	O
in	O
NAD.	O
Oriented	B-Delirium
x3.	B-Delirium
Mood,	O
affect	O
appropriate.	O
VS:	O
Tm	O
98.4	O
BP	O
112-135/50-79	O
HR	O
___	O
SaO2	O
97-98%	O
on	O
RA	O
Wt	O
81.4	O
kg	O
from	O
82.6	O
kg	O
on	O
admission	O
I:	O
858	O
O:500+200	O
overnight	O
NECK:	O
Supple,	O
JVP	O
not	O
visualized	O
at	O
90	O
degrees	O
CARDIAC:	O
PMI	O
located	O
in	O
___	O
intercostal	O
space,	O
midclavicular	O
line.	O
RR,	O
normal	O
S1,	O
S2.	O
No	O
murmurs,	O
rubs	O
or	O
gallops.	O
No	O
thrills,	O
lifts.	O
LUNGS:	O
No	O
chest	O
wall	O
deformities,	O
scoliosis	O
or	O
kyphosis.	O
Resp	O
were	O
unlabored,	O
no	O
accessory	O
muscle	O
use.	O
CTAB--no	O
crackles,	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
non-tender,	O
not	O
distended.	O
No	O
HSM	O
or	O
tenderness.	O
EXTREMITIES:	O
No	O
clubbing,	O
cyanosis	O
or	O
edema.	O
Pertinent	O
Results:	O
___	O
12:03PM	O
WBC-5.5	O
RBC-5.32	O
HGB-14.9	O
HCT-45.5	O
MCV-86	O
MCH-28.0	O
MCHC-32.7	O
RDW-13.6	O
___	O
12:03PM	O
NEUTS-59.7	O
___	O
MONOS-5.7	O
EOS-0.4	O
BASOS-0.6	O
___	O
12:03PM	O
PLT	O
COUNT-162	O
___	O
12:03PM	O
___	O
PTT-29.5	O
___	O
___	O
12:03PM	O
GLUCOSE-98	O
UREA	O
N-17	O
CREAT-1.0	O
SODIUM-139	O
POTASSIUM-4.3	O
CHLORIDE-104	O
TOTAL	O
CO2-27	O
ANION	O
GAP-12	O
___	O
09:15PM	O
CK-MB-4	O
cTropnT-0.05*	O
___	O
12:03PM	O
cTropnT-0.03*	O
___	O
07:55PM	O
cTropnT-0.09*	O
___	O
12:26PM	O
CHOLEST-169	O
TRIGLYCER-91	O
HDL	O
CHOL-79	O
CHOL/HDL-2.1	O
LDL(CALC)-72	O
ECG	O
___	O
Sinus	O
rhythm.	O
Mild	O
Q-T	O
interval	O
prolongation.	O
Non-diagnostic	O
Q	O
waves	O
in	O
leads	O
V1-V3	O
with	O
T	O
wave	O
inversions	O
in	O
leads	O
V1-V4.	O
Consider	O
myocardial	O
infarction	O
and/or	O
ischemia.	O
Since	O
the	O
previous	O
tracing	O
of	O
___	O
changes	O
in	O
R	O
wave	O
progression	O
and	O
precordial	O
T	O
wave	O
inversions	O
with	O
Q-T	O
interval	O
prolongation	O
are	O
new.	O
Clinical	O
correlation	O
is	O
suggested.	O
CXR	O
___	O
PA	O
and	O
lateral	O
views	O
of	O
the	O
chest	O
provided	O
demonstrate	O
clear,	O
well-expanded	O
lungs	O
without	O
focal	O
consolidation,	O
effusion	O
or	O
pneumothorax.	O
No	O
signs	O
of	O
CHF.	O
Cardiomediastinal	O
silhouette	O
is	O
normal.	O
Bony	O
structures	O
are	O
intact.	O
No	O
free	O
air	O
below	O
the	O
right	O
hemidiaphragm.	O
Cardiac	O
Catheterization	O
___	O
1.	O
Selective	O
coronary	O
angiography	O
in	O
this	O
right	O
dominant	O
system	O
demonstrated	O
single	O
vessel	O
obstructive	O
coronary	O
artery	O
disease.	O
The	O
___	O
was	O
free	O
of	O
angiographically	O
apparant	O
coronary	O
artery	O
disease.	O
The	O
LAD	O
was	O
totally	O
occluded	O
proximally.	O
The	O
LCX	O
and	O
RCA	O
had	O
mild,	O
non-obstructive	O
disease.	O
2.	O
Limited	O
resting	O
hemodynamics	O
demonstrated	O
normal	O
systemic	O
arterial	O
blood	O
pressure	O
with	O
a	O
central	O
aortic	O
blood	O
pressure	O
of	O
123/70	O
mmHg.	O
3.	O
Successful	O
PTCA	O
and	O
stenting	O
of	O
the	O
proximal	O
LAD	O
with	O
a	O
2.5	O
x	O
20	O
mm	O
Promus	O
Element	O
___	O
to	O
3.0	O
mm	O
(see	O
___	O
comments).	O
Echocardiogram	O
___	O
No	O
atrial	O
septal	O
defect	O
is	O
seen	O
by	O
2D	O
or	O
color	O
Doppler.	O
The	O
estimated	O
right	O
atrial	O
pressure	O
is	O
___	O
mmHg.	O
Left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal.	O
There	O
is	O
mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
with	O
focal	O
hypokinesis	O
of	O
the	O
distal	O
septum.	O
The	O
remaining	O
segments	O
contract	O
normally	O
(LVEF	O
=	O
55%).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
ascending	O
aorta	O
is	O
mildly	O
dilated.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	O
stenosis.	O
Trace	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	O
regurgitation.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
The	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
Normal	O
left	O
ventricular	O
cavity	O
size	O
with	O
mild	O
regional	O
systolic	O
dysfunction	O
c/w	O
CAD.	O
Dilated	O
ascending	O
aorta.	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
M	O
with	O
H/O	O
prostate	O
cancer	O
and	O
hyperlipidemia	O
referred	O
from	O
PCP	O
and	O
___	O
office	O
for	O
___	O
week	O
h/o	O
intermittent	O
exertional	O
chest	O
pain,	O
newly	O
diagnosed	O
anterior	O
T	O
wave	O
inversions	O
with	O
elevated	O
TnT,	O
found	O
to	O
have	O
total	O
proximal	O
LAD	O
occlusion	O
on	O
coronary	O
angiography,	O
now	O
s/p	O
DES	O
to	O
mid	O
LAD.	O
#	O
CAD/NSTEMI:	O
Patient	O
admitted	O
with	O
h/o	O
intermittent	O
exertional	O
chest	O
pain	O
and	O
shortness	O
of	O
breath	O
since	O
___,	O
found	O
to	O
have	O
new	O
TWI	O
on	O
EKG	O
and	O
troponin	O
elevation,	O
consistent	O
with	O
an	O
anterior	O
NSTEMI.	O
Patient	O
was	O
chest	O
pain	O
free	O
on	O
the	O
day	O
of	O
presentation.	O
Coronary	O
angiography	O
showed	O
proximal	O
LAD	O
total	O
occlusion	O
treated	O
with	O
one	O
DES	O
to	O
the	O
mid	O
LAD.	O
He	O
received	O
an	O
Integrilin	O
gtt	O
for	O
9	O
hours	O
post-PCI.	O
Plavix	O
and	O
beta	O
blocker	O
were	O
begun,	O
and	O
he	O
was	O
continued	O
on	O
ASA	O
325	O
mg	O
daily.	O
TTE	O
post	O
cath	O
showed	O
mild	O
regional	O
systolic	O
dysfunction	O
consistent	O
with	O
CAD	O
and	O
preserved	O
overall	O
LVEF	O
55%.	O
Patiet	O
was	O
discharged	O
home	O
with	O
plan	O
for	O
close	O
cardiology	O
followup.	O
#	O
Elevated	O
BP:	O
Patient	O
did	O
not	O
have	O
h/o	O
hypertension.	O
BP	O
elevated	O
on	O
arrival	O
to	O
the	O
floor	O
150s/90s.	O
Started	O
beta	O
blocker	O
as	O
above.	O
#	O
Hyperlipidemia:	O
Changed	O
home	O
simvastatin	O
40	O
mg	O
to	O
atorvastatin	O
80	O
mg	O
given	O
acute	O
coronary	O
syndrome	O
on	O
prior	O
regime	O
despite	O
presentation	O
LDL	O
of	O
72.	O
TRANSITIONAL	O
ISSUES:	O
-CAD/NSTEMI:	O
Consider	O
initiation	O
of	O
ACE-I	O
as	O
outpatient,	O
as	O
tolerated.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Simvastatin	O
40	O
mg	O
PO	O
DAILY	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
4.	O
Fish	O
Oil	O
(Omega	O
3)	O
1000	O
mg	O
PO	O
BID	O
5.	O
Vitamin	O
D	O
400	O
UNIT	O
PO	O
DAILY	O
6.	O
Vitamin	O
B	O
Complex	O
1	O
CAP	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
RX	O
*clopidogrel	O
75	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
2.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
RX	O
*metoprolol	O
succinate	O
25	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
3.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
4.	O
Atorvastatin	O
80	O
mg	O
PO	O
DAILY	O
RX	O
*atorvastatin	O
80	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
5.	O
Aspirin	O
325	O
mg	O
PO	O
DAILY	O
RX	O
*aspirin	O
325	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
6.	O
Fish	O
Oil	O
(Omega	O
3)	O
1000	O
mg	O
PO	O
BID	O
7.	O
Vitamin	O
B	O
Complex	O
1	O
CAP	O
PO	O
DAILY	O
8.	O
Vitamin	O
D	O
400	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Non-ST	O
segment	O
elevation	O
myocardial	O
infarction	O
Coronary	O
artery	O
disease	O
Hyperlipidemia	O
Elevated	O
blood	O
pressure	O
without	O
prior	O
history	O
of	O
hypertension	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
while	O
you	O
were	O
here	O
at	O
___.	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
after	O
your	O
PCP/Cardiologist	O
found	O
EKG	O
changes	O
that	O
were	O
concerning	O
for	O
coronary	O
artery	O
disease	O
and	O
felt	O
that	O
this	O
may	O
be	O
related	O
to	O
the	O
chest	O
pain	O
you	O
had	O
been	O
experiencing.	O
While	O
you	O
were	O
here	O
your	O
cardiac	O
enzymes	O
increased	O
which	O
indicates	O
that	O
you	O
had	O
a	O
small	O
heart	O
attack,	O
which	O
may	O
have	O
been	O
triggered	O
by	O
the	O
shoveling	O
you	O
were	O
doing	O
over	O
the	O
weekend.	O
You	O
were	O
treated	O
with	O
medications	O
and	O
underwent	O
a	O
cardiac	O
catheterization	O
where	O
we	O
found	O
a	O
very	O
tight	O
area	O
in	O
one	O
of	O
the	O
major	O
arteries	O
supply	O
the	O
blood	O
to	O
your	O
heart	O
muscle.	O
A	O
stent	O
was	O
placed	O
in	O
this	O
and	O
you	O
were	O
started	O
on	O
multiple	O
medications	O
to	O
try	O
to	O
help	O
your	O
heart	O
heal,	O
prevent	O
future	O
heart	O
attacks	O
and	O
to	O
keep	O
your	O
stent	O
open.	O
It	O
is	O
critical	O
that	O
you	O
take	O
your	O
clopidogrel	O
(plavix)	O
every	O
single	O
day	O
to	O
prevent	O
the	O
stent	O
from	O
closing.	O
Followup	O
Instructions:	O
___	O

